| Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
| NanoTemper Technologies GmbH. (5/18/22). "Press Release: NanoTemper Technologies Welcomes Andreas Schmitz as Its First Chief Human Resources Officer". Munich. |
2022-05-18 |
| Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON. |
2022-05-17 |
| BeiGene, Ltd.. (5/17/22). "Press Release: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland". Cambridge, MA, Basel & Beijing. |
2022-05-17 |
| Nouscom AG. (5/17/22). "Press Release: Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform". Basel. |
2022-05-17 |
| Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. |
2022-05-17 |
| Valneva S.E.. (5/16/22). "Press Release: Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement". Saint-Herblain. |
2022-05-16 |
| Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. |
2022-05-16 |
| Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. |
2022-05-16 |
| HH2E AG. (5/16/22). "Press Release: HH2E Concludes Equity Raising Round with HydrogenOne and Foresight and Secures Funding Agreement for Five Large Scale Projects". |
2022-05-16 |
| SciRhom GmbH. (5/12/22). "Press Release: SciRhom Announces Addition to the Management Team". Munich. |
2022-05-12 |
| Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. |
2022-05-12 |
| Sofinnova Partners. (5/12/22). "Press Release: Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform". Milan. |
2022-05-12 |
| Enzymaster Deutschland GmbH. (5/12/22). "Press Release: Enzymaster Completes Round-C Financing to Accelerate Innovation, Increase Capabilities, and Expand Capacity". Düsseldorf. |
2022-05-12 |
| Isopmorphic Labs Ltd.. (5/12/22). "Press Release: Isomorphic Labs Announces First Phase of Management Team". London. |
2022-05-12 |
| Proteona Pte. Ltd.. (5/11/22). "Press Release: Proteona Opens New Laboratory in Singapore. New Facility Will also Serve as Regional Headquarters for Singleron in Asia". Singapore. |
2022-05-11 |
| Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. |
2022-05-11 |
| Qiagen N.V.. (5/11/22). "Press Release: Qiagen Proposes Expansion of Supervisory Board. Dr. Eva Pisa Proposed as a New Member to the Supervisory Board". Venlo. |
2022-05-11 |
| Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
| Evotec SE. (5/10/22). "Press Release: Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation". Hamburg. |
2022-05-10 |
| Bruker Corporation. (5/10/22). "Press Release: Bruker and TOFwerk Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets". Thun. |
2022-05-10 |
| Pfizer Inc.. (5/10/22). "Press Release: Pfizer to Acquire Biohaven Pharmaceuticals". New York, NY & New Haven, CT. |
2022-05-10 |
| HBM Healthcare Investments Ltd.. (5/10/22). "Press Release: Pfizer to Acquire HBM Portfolio Company Biohaven Pharmaceuticals in USD 11.6 Billion Deal". Zug. |
2022-05-10 |
| NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. |
2022-05-09 |
| InxMed Co., Ltd.. (5/9/22). "Press Release: InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers". Nanjing. |
2022-05-09 |
| Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London. |
2022-05-09 |
| ADC Therapeutics S.A.. (5/9/22). "Press Release: ADC Therapeutics Announces CEO Transition. Co-Founder Chris Martin Transitions CEO Role to Industry Veteran Ameet Mallik". Lausanne. |
2022-05-09 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (5/9/22). "Press Release: SHS Strengthens Finance Team. Lukas Maucher Joins Tübingen-based Private Equity Investor as CFO". |
2022-05-09 |
| Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. |
2022-05-05 |
| Coriolis Pharma Research GmbH. (5/4/22). "Press Release: Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer". Martinsried. |
2022-05-04 |
| European Spatial Biology Center (ESBC). (5/4/22). "Press Release: The European Spatial Biology Center (ESBC). State-of-the-Art Spatial Biology Services Enabled at Scale in Leuven". |
2022-05-04 |
| Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich. |
2022-05-03 |
| Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. |
2022-05-03 |
| Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel. |
2022-05-03 |
| Swiss Biotech Association. (5/3/22). "Press Release: Swiss Biotech Association Elects Molecular Partners’ CEO Patrick Amstutz as President of the Board of Directors". |
2022-05-03 |
| Fresenius Medical Care AG & Co. KGaA. (5/3/22). "Press Release: Dr. Carla Kriwet to Succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care". |
2022-05-03 |
| GlycoEra AG. (5/3/22). "Press Release: GlycoEra AG Appoints Ganesh V. Kaundinya as President and Chief Executive Officer". Schlieren & Boston, MA. |
2022-05-03 |
| Corden Pharma International GmbH. (5/2/22). "Press Release: Astorg to Acquire Leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG". Basel. |
2022-05-02 |
| Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA. |
2022-05-02 |
| Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt. |
2022-04-29 |
| Bionter AG. (4/27/22). "Press Release: Bionter AG Secures $3 Million in Series Seed Financing Led by Dynamk Capital". Riehen. |
2022-04-27 |
| Berlin, State of. (4/26/22). "Press Release: Memorandum Signed on Establishing a Center of Gene and Cell Therapy – The State of Berlin, Bayer, and Charité Are Planning a Health Care Lighthouse Project in the Mitte Borough". Berlin. |
2022-04-26 |
| Mainz Biomed N.V.. (4/26/22). "Press Release: Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer". Berkeley, CA & Mainz. |
2022-04-26 |
| Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. |
2022-04-26 |
| Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment". |
2022-04-26 |
| Temedica GmbH. (4/26/22). "Press Release: Temedica Wins further Renowned Industry Representatives for Expert Advisory Board". Munich. |
2022-04-26 |
| Valneva S.E.. (4/25/22). "Press Release: Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate". Saint-Herblain. |
2022-04-25 |
| Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich. |
2022-04-25 |
| University of Bonn. (4/25/22). "Press Release: Successful Spin-off from the University of Bonn and LS. APIS Assay Technologies Ltd Acquires Startup Clickmer Systems". |
2022-04-25 |
| Eppendorf SE. (4/22/22). "Press Release: Eppendorf Builds New Site in Wismar for High-tech Polymers Used in Laboratories". Wismar & Hamburg. |
2022-04-22 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. |
2022-04-22 |
| Bayer AG. (4/22/22). "Press Release: Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms". Monheim. |
2022-04-22 |
| CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. |
2022-04-21 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. |
2022-04-21 |
| Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin. |
2022-04-21 |
| VectivBio Holding AG. (4/21/22). "Press Release: VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications". Basel. |
2022-04-21 |
| VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". |
2022-04-20 |
| VantAI. (4/20/22). "Press Release: VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders". new York, NY & Ingelheim. |
2022-04-20 |
| Carl Zeiss Meditec AG. (4/19/22). "Press Release: Carl Zeiss Meditec Acquires Two Manufacturers of Surgical Instruments". Jena. |
2022-04-19 |
| Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden. |
2022-04-14 |
| CDR-Life AG. (4/13/22). "Press Release: CDR-Life Announces $76 Million Raised in Series A Funding". Zürich. |
2022-04-13 |
| Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. |
2022-04-13 |
| Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. |
2022-04-13 |
| Cimeio Therapeutics AG. (4/13/22). "Press Release: Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A". Basel & Boston, MA. |
2022-04-13 |
| Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin. |
2022-04-13 |
| Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. |
2022-04-12 |
| BioNTech SE. (4/11/22). "Press Release: BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines". Mainz & Beminster, NJ. |
2022-04-11 |
| CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. |
2022-04-11 |
| Recipharm AB. (4/11/22). "Press Release: Recipharm Completes US Biologics Acquisitions". |
2022-04-11 |
| Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. |
2022-04-10 |
| Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. |
2022-04-08 |
| H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. |
2022-04-08 |
| Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. |
2022-04-08 |
| IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC. |
2022-04-07 |
| Enable Medicine. (4/7/22). "Press Release: Enable Medicine Raises $60M to Build the Search Engine For Biology". Menlo Park, CA. |
2022-04-07 |
| ViGeneron GmbH. (4/6/22). "Press Release: ViGeneron Signs Gene Therapy Strategic Collaboration and Option Agreement with Regeneron for One Inherited Retinal Disease Target". Munich. |
2022-04-06 |
| Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. |
2022-04-06 |
| Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". |
2022-04-06 |
| NanoTemper Technologies GmbH. (4/6/22). "Press Release: NanoTemper Technologies and PharmAI Launch Proto, a Free AI Tool to Quickly Determine which Protein Labeling Strategy Works Best for Molecular Interaction Measurements". Munich & Dresden. |
2022-04-06 |
| Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt. |
2022-04-05 |
| Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. |
2022-04-05 |
| Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel. |
2022-04-04 |
| AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". |
2022-04-04 |
| Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. |
2022-04-04 |
| Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. |
2022-04-04 |
| Celeris Therapeutics GmbH. (4/4/22). "Press Release: Celeris Therapeutics and Boehringer Ingelheim Enter Collaboration to Develop Next-generation Targeted Protein Degraders". Menlo Park, CA. |
2022-04-04 |
| Bayer AG. (4/1/22). "Press Release: Breakthrough Innovation Forum. Bayer Set to Drive Breakthrough Innovations in the Life Sciences". Leverkusen. |
2022-04-01 |
| Biovox GmbH. (4/22). "Press Release: Successful Pre-Seed-Round for Biovox". |
2022-04-01 |
| Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin. |
2022-03-31 |
| Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". |
2022-03-31 |
| High-Tech Gründerfonds Management GmbH. (3/31/22). "Press Release: Improving ARDS Treatment with Digital Twins. Ebenbuild Secures Seed Financing Round Led by Bayern Kapital and High-Tech Gründerfonds". Munich, Bonn & Landshut. |
2022-03-31 |
| Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. |
2022-03-31 |
| Cytosurge AG. (3/30/22). "Press Release: Cytosurge Launches Cell Line Engineering Services Based on Proprietary FluidFM Technology". Zurich. |
2022-03-30 |
| VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel. |
2022-03-30 |
| CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. |
2022-03-30 |
| Neuron23 Inc.. (3/30/22). "Press Release: Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease". South San Francisco, CA. |
2022-03-30 |
| Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris. |
2022-03-29 |
| XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". |
2022-03-29 |
| Core Biogenesis SAS. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". |
2022-03-29 |
| Irubis GmbH. (3/24/22). "Press Release: Irubis Receives 500k € as Convertible Loan from the EIC Fund, the Equity Instrument of the “EIC Accelerator Pilot”, under HORIZON 2020 Program". Munich. |
2022-03-24 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 13 14 15 ... 37 38 39 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
